Inactive Instrument
ARYx Therapeutics, Inc. Stock Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 9.03M 7.9M 7.29M 6.73M 12.77M 862M 12.99M 87.09M 34.2M 424M 33.92M 33.18M 1.46B | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41M 9.98M 9.2M 8.5M 16.13M 1.09B 16.4M 110M 43.18M 536M 42.83M 41.89M 1.84B | EV / Sales 2008 |
4,019,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +47.06% | +4.62% | - | - | 33 | |
| +1.84% | -0.66% | +59.82% | +94.48% | 54.88B | |
| +0.55% | -5.49% | +57.65% | +130.96% | 54.63B | |
| -2.24% | +3.59% | +17.75% | +469.23% | 25.06B | |
| -1.60% | -6.21% | -18.96% | -16.06% | 23.14B | |
| -1.69% | -1.27% | +39.51% | -8.30% | 19.87B | |
| +0.44% | +2.68% | +36.77% | -27.46% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +364.56% | 16.5B | |
| -2.42% | -3.72% | +47.02% | +635.77% | 15.75B | |
| -1.05% | +1.16% | +25.95% | +191.69% | 14.2B | |
| Average | +3.63% | -0.28% | +51.18% | +203.87% | 26.84B | |
| Weighted average by Cap. | -0.42% | -1.45% | +50.50% | +173.16% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.25 15.91 14.7 27.89 1.88K 28.36 190.14 74.67 926.72 74.06 72.45 3.19K | - |
| Net income | -31.22M -27.31M -25.19M -23.26M -44.14M -2.98B -44.88M -301M -118M -1.47B -117M -115M -5.04B | -33.17M -29.01M -26.76M -24.71M -46.9M -3.16B -47.68M -320M -126M -1.56B -125M -122M -5.36B |
| Net Debt | -29.9 -26.16 -24.13 -22.28 -42.28 -2.85K -42.99 -288.28 -113.21 -1.41K -112.28 -109.84 -4.83K | 2.37 2.07 1.91 1.77 3.35 226.13 3.41 22.86 8.98 111.4 8.9 8.71 382.97 |
Employees
-
Choose MarketScreener 
